Enrollment change • Trial completion date • Trial termination • Trial primary completion date • Metastases
|
HER-2 (Human epidermal growth factor receptor 2) • ER (Estrogen receptor) • PGR (Progesterone receptor) • CD4 (CD4 Molecule)
|
ER positive • HER-2 negative
|
sirolimus • racemetyrosine (SM-88)